The third largest holder is Vanguard Group Inc, which now holds $83.26 million worth of this stock and that ownership represents almost 6.03% of its market capitalization. Macquarie Group Ltd. lifted its position in shares of Evolent Health by 44.7% during the 4th quarter. The stock has "Buy" rating by KeyBanc Capital Markets on Wednesday, January 10. Evolent Health had 10 analyst reports since November 16, 2017 according to SRatingsIntel. (NYSE:EVH) rating on Wednesday, January 10. Earnings, adjusted for non-recurring costs and stock option expense, were 2 cents per share. This is 54.27 % from the last stock close price. The technology company reported ($0.10) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.10). Evolent Health had a negative net margin of 14.05% and a negative return on equity of 3.51%. The company had revenue of $113.97 million during the quarter, compared to analysts' expectations of $111.09 million.
A number of brokerages recently issued reports on EVH. Evolent Health Inc Class A Com (NYSE:EVH)'s price to free cash flow for trailing twelve months is 0. (NYSE:EVH) earned "Buy" rating by Cantor Fitzgerald on Tuesday, January 2. Wells Fargo maintained the shares of EVH in report on Wednesday, February 28 with "Outperform" rating. As per Zacks simplified descending rating scale the ABR rank is displayed in the range of 1 to 5 where 1 represents Strong Buy and 5 a Strong Sell. Jefferies Group set a $22.00 price objective on Evolent Health and gave the stock a "buy" rating in a report on Tuesday, February 13th. The firm earned "Buy" rating on Monday, December 11 by Canaccord Genuity. The company presently has a consensus rating of "Buy" and a consensus price target of $25.33.
In related news, Director Unitedhealth Group Inc sold 3,040,000 shares of the business's stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $13.70, for a total value of $41,648,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. However the six-month change in the insider ownership was recorded -65.49%, as well as three-month change in the institutional ownership was recorded 0%.
Short interest or otherwise called the percentage of a stock's tradable shares now being shorted is another data that investors use to get a handle on sentiment.
The PEG ratio is used to determine a stock's value while taking the company's earnings growth into account, and is considered to provide a more complete picture than the P/E. Evolent Health Inc Class A Com (NYSE:EVH) has a current PEG of 0. However the company's price to cash per share for most recent quarter stands at 3.12. Finally, Bank of Montreal Can boosted its position in shares of Evolent Health by 124.0% in the fourth quarter. It helps you quickly get a picture of where Wall Street stands on a stock without reading huge research reports. Riverbridge Partners LLC grew its holdings in Evolent Health by 23.9% during the 4th quarter. Our transition to value- based payments is critically important to our mission, as it considers the whole health of a patient in reimbursing providers.
"In Evolent, we have a partner who understands and shares our mission, values and passion for being a true health care change leader and supporting the most vulnerable members of our communities", said SOMOS Founder and Board Chairman Dr. Ramon Tallaj. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.85 and a current ratio of 2.85.
The stock has a market cap of $1.38B and the number of outstanding shares has been calculated 76.29M.
President Buhari is back to Nigeria ahead of schedule
The 75-year-old president spent five months of last year in London on medical leave for an undisclosed ailment. However, his plane touched down at the Nnamdi Azikiwe International Airport, Abuja, at 6:47pm on Friday.